1. Home
  2. WST vs TLK Comparison

WST vs TLK Comparison

Compare WST & TLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • TLK
  • Stock Information
  • Founded
  • WST 1923
  • TLK 1884
  • Country
  • WST United States
  • TLK Indonesia
  • Employees
  • WST N/A
  • TLK N/A
  • Industry
  • WST Medical/Dental Instruments
  • TLK Telecommunications Equipment
  • Sector
  • WST Health Care
  • TLK Telecommunications
  • Exchange
  • WST Nasdaq
  • TLK Nasdaq
  • Market Cap
  • WST 18.9B
  • TLK 16.1B
  • IPO Year
  • WST N/A
  • TLK 1995
  • Fundamental
  • Price
  • WST $246.18
  • TLK $20.08
  • Analyst Decision
  • WST Buy
  • TLK
  • Analyst Count
  • WST 7
  • TLK 0
  • Target Price
  • WST $332.50
  • TLK N/A
  • AVG Volume (30 Days)
  • WST 841.4K
  • TLK 866.2K
  • Earning Date
  • WST 07-24-2025
  • TLK 07-31-2025
  • Dividend Yield
  • WST 0.36%
  • TLK 5.21%
  • EPS Growth
  • WST N/A
  • TLK N/A
  • EPS
  • WST 6.68
  • TLK 0.01
  • Revenue
  • WST $2,960,200,000.00
  • TLK $9,097,469,437.00
  • Revenue This Year
  • WST $5.70
  • TLK $3.12
  • Revenue Next Year
  • WST $6.05
  • TLK $3.19
  • P/E Ratio
  • WST $36.83
  • TLK $14.39
  • Revenue Growth
  • WST 2.90
  • TLK N/A
  • 52 Week Low
  • WST $187.43
  • TLK $13.15
  • 52 Week High
  • WST $352.33
  • TLK $21.00
  • Technical
  • Relative Strength Index (RSI)
  • WST 57.91
  • TLK 76.82
  • Support Level
  • WST $237.18
  • TLK $17.88
  • Resistance Level
  • WST $244.36
  • TLK $20.98
  • Average True Range (ATR)
  • WST 5.82
  • TLK 0.30
  • MACD
  • WST -0.41
  • TLK 0.24
  • Stochastic Oscillator
  • WST 51.10
  • TLK 75.41

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TLK PT Telekomunikasi Indonesia Tbk

PT Telkom Indonesia (Persero) Tbk is the integrated telecommunications provider in Indonesia. The company is focusing on dividing business into 3 Digital Business Domains namely, digital connectivity, digital platform, and digital services. It also provides a wide range of other communication services, including telephone network, interconnection services, multimedia, data and internet communication-related services, satellite transponder leasing, leased line, intelligent network and related services, cable television, and VoIP services. The group derives revenue from product lines: Mobile, Consumer, Enterprise, WIB and Others.

Share on Social Networks: